Effect of Roa Damascena oil on migrain headache

Evaluation the Effect of Topical Product Containing Rosa Damascena Oil in Migraine Treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014071318462N1

Enrollment

Registered

2016-08-30

Start date

2016-08-28

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine without aura [common migraine]

Interventions

Intervention 1: Intervention group:Rosa Damascena oil 1 cc right temporal region/1 cc frontal/1 cc left temporal region duration:1 month massage on skin for 1 minute. Intervention 2: Control group:par

Treatment - Drugs

Placebo

Intervention group:Rosa Damascena oil 1 cc right temporal region/1 cc frontal/1 cc left temporal region duration:1 month massage on skin for 1 minute

Control group:paraffin 1 cc right temporal region/1 cc frontal/1 cc left temporal region duration:1 month massage on skin for 1 minute

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: between 20-50 years; patient with migraine without aura; at least 1 year after the onset of illness; voluntary consent of the patient Exclusion criteria: have a headache more than 15 days per month; Any disorder or disability of mind that their cooperation with corrupted; Incorrect use of the drug; any history of allergies; an underlying medical condition such as diabetes, hypertension, heart disease, organs and peripheral vascular problems,liver disease, kidney, gastrointestinal, gynecological and neurological diseases than any migraines; an allergy or skin irritation and other side effects possible during the intervention; no response to treatment and need to complete treatment or extreme;n ot referring to control symptoms Ckech complete list

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical status improvement. Timepoint: before intervention/1 week later/2 week later/1 months later. Method of measurement: Questionnaire.	—

Secondary

Measure	Time frame
Any side effect of drug. Timepoint: 1 week/2 week/1 month after taking medication. Method of measurement: quesionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBita Ebadollahzadeh Haghani

Faculty of Traditional Medicine

haghanib891@mums.ac.ir, bita5110@yahoo.com+98 51 3855 2188

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026